Product NDC: | 0409-1209 |
Proprietary Name: | Lidocaine Hydrochloride and Epinephrine |
Non Proprietary Name: | LIDOCAINE HYDROCHLORIDE ANHYDROUS and EPINEPHRINE |
Active Ingredient(s): | 5; 15 ug/mL; mg/mL & nbsp; LIDOCAINE HYDROCHLORIDE ANHYDROUS and EPINEPHRINE |
Administration Route(s): | EPIDURAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1209 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA088571 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100405 |
Package NDC: | 0409-1209-05 |
Package Description: | 400 AMPULE in 1 CASE (0409-1209-05) > 5 mL in 1 AMPULE |
NDC Code | 0409-1209-05 |
Proprietary Name | Lidocaine Hydrochloride and Epinephrine |
Package Description | 400 AMPULE in 1 CASE (0409-1209-05) > 5 mL in 1 AMPULE |
Product NDC | 0409-1209 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LIDOCAINE HYDROCHLORIDE ANHYDROUS and EPINEPHRINE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | EPIDURAL |
Start Marketing Date | 20100405 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE ANHYDROUS |
Strength Number | 5; 15 |
Strength Unit | ug/mL; mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |